Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
47 participants
OBSERVATIONAL
2017-08-28
2018-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cardiovascular Risk After Preeclampsia
NCT05277233
Cardiac Dysfunction and Remodeling in Patients With Preeclampsia
NCT04162236
Berlin-Brandenburg Pregnancy Cohort
NCT03313024
Persistent Postpartum Cardiovascular Dysfunction in Patients With Preeclampsia
NCT04063397
Cardiovascular an Echocardiographic Assessment in Hypertension During Pregnancy
NCT01068002
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
PE
Women with a history or preeclampsia, between 18 - 50 years of age, 0.5 - 20 years postpartum
No interventions assigned to this group
Control
Age-matched women without any birth complications, between 18 - 50 years of age, 0.5 - 20 years postpartum
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* cases: diagnosis of preeclampsia during the index pregnancy
* controls: age and BMI matched
Exclusion Criteria
* kidney insufficiency (GFR \< 30 ml/min/)
* claustrophobia
* contrast medium allergy
* current pregnancy/ lactation
* chronic hypertension (\> 140/90)
* diagnosis of previous cardiovascular disease
* body weight over 120 kg
* big tattoos in thorax area
18 Years
50 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Charite University, Berlin, Germany
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Florian Herse
PhD
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Experimental and Clinical Research Center (ECRC)
Berlin, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PPC1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.